Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Hepatocellular | 4 | 2023 | 145 | 2.770 |
Why?
|
| Liver Neoplasms | 4 | 2023 | 190 | 2.680 |
Why?
|
| MicroRNAs | 4 | 2022 | 426 | 2.050 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2020 | 147 | 1.960 |
Why?
|
| Fluorocarbons | 2 | 2023 | 26 | 1.730 |
Why?
|
| Prostatic Neoplasms | 4 | 2022 | 935 | 1.620 |
Why?
|
| Autophagy | 4 | 2022 | 116 | 1.560 |
Why?
|
| Neoplasms | 3 | 2021 | 1103 | 1.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2022 | 807 | 1.000 |
Why?
|
| Bacterial Toxins | 1 | 2023 | 44 | 0.890 |
Why?
|
| Cell Proliferation | 7 | 2022 | 1198 | 0.880 |
Why?
|
| Alkanesulfonic Acids | 1 | 2022 | 8 | 0.870 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2021 | 12 | 0.810 |
Why?
|
| Vaccines | 1 | 2021 | 55 | 0.750 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 222 | 0.740 |
Why?
|
| Environmental Pollutants | 1 | 2022 | 179 | 0.720 |
Why?
|
| Adipocytes | 1 | 2020 | 58 | 0.710 |
Why?
|
| Fatty Liver | 1 | 2020 | 64 | 0.680 |
Why?
|
| Humans | 18 | 2023 | 37093 | 0.660 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 68 | 0.660 |
Why?
|
| Oncogenes | 1 | 2018 | 43 | 0.660 |
Why?
|
| Exosomes | 1 | 2020 | 101 | 0.660 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 76 | 0.650 |
Why?
|
| Receptors, Notch | 1 | 2018 | 33 | 0.640 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 132 | 0.640 |
Why?
|
| Signal Transduction | 4 | 2020 | 1908 | 0.630 |
Why?
|
| Serotonin | 1 | 2018 | 123 | 0.620 |
Why?
|
| Cell Line, Tumor | 5 | 2023 | 2231 | 0.620 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 172 | 0.600 |
Why?
|
| Cell Movement | 4 | 2022 | 571 | 0.600 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 213 | 0.590 |
Why?
|
| Health Status Disparities | 1 | 2020 | 642 | 0.470 |
Why?
|
| Fibrosis | 2 | 2023 | 159 | 0.410 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 803 | 0.400 |
Why?
|
| North Carolina | 2 | 2021 | 104 | 0.400 |
Why?
|
| 3' Untranslated Regions | 2 | 2022 | 74 | 0.370 |
Why?
|
| Male | 7 | 2022 | 20025 | 0.350 |
Why?
|
| Animals | 6 | 2023 | 15081 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 269 | 0.330 |
Why?
|
| Cell Survival | 2 | 2019 | 864 | 0.260 |
Why?
|
| Mice | 3 | 2020 | 5913 | 0.240 |
Why?
|
| Microcystins | 1 | 2023 | 8 | 0.230 |
Why?
|
| Unfolded Protein Response | 1 | 2022 | 18 | 0.220 |
Why?
|
| Cadmium | 1 | 2023 | 58 | 0.210 |
Why?
|
| Zebrafish | 1 | 2023 | 128 | 0.210 |
Why?
|
| Sirolimus | 1 | 2022 | 60 | 0.200 |
Why?
|
| Apoptosis | 2 | 2019 | 1398 | 0.200 |
Why?
|
| Leptin | 1 | 2022 | 118 | 0.190 |
Why?
|
| Metabolism | 1 | 2020 | 9 | 0.190 |
Why?
|
| Prostate-Specific Antigen | 1 | 2022 | 118 | 0.190 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 53 | 0.190 |
Why?
|
| Glycolysis | 1 | 2020 | 68 | 0.180 |
Why?
|
| Infant | 1 | 2023 | 1046 | 0.180 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 583 | 0.180 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2018 | 2 | 0.170 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 37 | 0.170 |
Why?
|
| Transplantation, Heterologous | 1 | 2018 | 90 | 0.160 |
Why?
|
| Transfection | 1 | 2020 | 523 | 0.160 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 51 | 0.160 |
Why?
|
| Logistic Models | 1 | 2021 | 923 | 0.160 |
Why?
|
| RNA Interference | 1 | 2019 | 243 | 0.160 |
Why?
|
| Rural Population | 1 | 2020 | 294 | 0.160 |
Why?
|
| Comorbidity | 1 | 2020 | 623 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 187 | 0.150 |
Why?
|
| Community-Based Participatory Research | 1 | 2021 | 317 | 0.150 |
Why?
|
| Cell Cycle | 1 | 2019 | 326 | 0.150 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 219 | 0.150 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 180 | 0.150 |
Why?
|
| Prognosis | 1 | 2019 | 739 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 356 | 0.140 |
Why?
|
| Obesity | 1 | 2022 | 1067 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 1609 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2721 | 0.110 |
Why?
|
| Risk Factors | 1 | 2020 | 3562 | 0.100 |
Why?
|
| Young Adult | 1 | 2021 | 4268 | 0.100 |
Why?
|
| Adolescent | 1 | 2021 | 5363 | 0.090 |
Why?
|
| United States | 1 | 2020 | 4223 | 0.090 |
Why?
|
| Middle Aged | 1 | 2021 | 10129 | 0.070 |
Why?
|
| Adult | 1 | 2021 | 11712 | 0.070 |
Why?
|
| Female | 1 | 2021 | 20969 | 0.050 |
Why?
|